News
Cancer-fighting T-cells, the immune system's primary enforcers, are scarce in the rare kidney cancer called chromophobe renal ...
Aussie researchers have used CRISPR gene editing tools to “armor” chimeric antigen receptor (CAR) T cells to activate additional cancer-fighting proteins at the tumor site, enabling them to target ...
Each time a cell divides, a small section of each chromosome's protective cap—the telomere—is worn away. Most cells use an ...
Digital imaging of suspected skin cancers has dramatically cut waiting times for diagnosis and treatment in Nottinghamshire.
The American Heritage Museum in Hudson is hosting Lynn native, Air Force veteran and award-winning author George Hayward for a discussion of his book “The Party Dolls: The True, Tragic Story of Two ...
A novel chimeric antigen receptor T-cell therapy may benefit patients with B-cell lymphomas who previously relapsed following ...
Regeneron, playing catch up with J&J and Pfizer, wins FDA approval for Lynozyfic in multiple myeloma
Another BCMA-targeted agent has arrived for the treatment of multiple myeloma. | After a delay, Regeneron’s BCMA-directed ...
Orca-T shows significant promise in reducing chronic graft-vs-host disease and improving survival rates in allogeneic ...
1d
MedPage Today on MSNNew Bispecific T-Cell Engager Approved for Multiple MyelomaA B-cell maturation antigen (BCMA)-directed bispecific antibody, linvoseltamab is indicated for adult patients who have ...
After a groundbreaking surgery using codfish skin grafts, Kere, the bald eagle, was rehabilitated and released back into the ...
The field of cellular immunotherapy has undergone a profound transformation in recent years, with autologous chimeric antigen receptor (CAR) T-cell therapies emerging as the standard-of-care option ...
Engineered chip mimics bone marrow and immune system, offering a faster, tailored path for cancer immunotherapy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results